In this week’s video, Dr. Brian Durie points to ASCO 2017 presentations on new multiple myeloma drug combinations, monoclonal antibodies, and checkpoint inhibitors; however, he finds there are “no major breakthroughs” on myeloma from this year’s meeting. BOTTOM LINE: |
|||
Have a question? Submit it to AskDrDurie@myeloma.org |
|||
IMF Chairman and Co-Founder Brian G.M. Durie, MD welcomes your questions about the latest myeloma treatments, research, controversies and quality of life issues. If you have a question you think might be of interest to the myeloma community, please send to askdrdurie@myeloma.org! |